“…Currently, the manufactured vaccines are designed to target the influenza A virus according to their subtypes, for example, the focus in recent year would be the H5N1 subtype of influenza A virus [7,8,9,10,11,12,13,14], and anti-flu drugs are designed to target neuraminidases and M2 protein [15,16]. It would be understandable that proteins should be different from one subtype to another.…”